Bcor缺失扰乱红系-巨核系造血并与Dnmt3a缺失协同诱发小鼠急性红白血病
在正常核型AML中约4%存在BCOR功能缺失突变,且常伴DNMT3a突变和预后不良。研究构建Bcor-/-小鼠,表现为红系发育受损(大红细胞症和贫血)及血小板生成增强,再构建Bcor-/-/Dnmt3a-/-双敲小鼠,完全外显地发生急性红白血病(AEL),伴c-Kit+和Ter119+原始细胞扩增、大细胞性贫血及血小板增多进行性减少。转录组分析提示GATA1-2和Mdm2、Tp53等表观遗传改变诱导红系偏斜,去甲基化药物可显著影响白血病负荷和总生存。
要点
- Bcor缺失导致红系发育受损和血小板生成增强,类似MDS/MPN特征。
- Bcor与Dnmt3a双缺失协同诱发完全外显的急性红白血病。
- 去甲基化药物可减轻AEL小鼠白血病负荷并改善总生存。
核心结论
- Bcor缺失扰乱红系-巨核系造血,与Dnmt3a缺失协同驱动急性红白血病发生。
- 去甲基化药物在该AEL模型中显示对白血病负荷和总生存的显著影响。
研究设计与样本
- 研究构建Bcor-/-单敲和Bcor-/-/Dnmt3a-/-双敲小鼠模型,并进行转录组分析。
主要发现
- Bcor-/-小鼠表现为大红细胞症、贫血和血小板生成增强。
- 双敲小鼠完全外显地发生急性红白血病,伴白细胞增多、c-Kit+和Ter119+原始细胞扩增、大细胞性贫血及血小板增多进行性减少。
- 双敲骨髓祖细胞转录组显示GATA1-2及Mdm2、Tp53等因子相关的表观遗传改变诱导红系偏斜。
关键数值与推荐
- 约4%的正常核型AML患者存在BCOR功能缺失突变,并与DNMT3a突变和预后不良相关。
临床怎么用
- 该模型提示去甲基化药物可能用于BCOR/DNMT3a共突变的高危急性红白血病。
局限性
- 研究为小鼠模型,结论向人类患者转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent loss-of-function mutations of BCL6 co-repressor (BCOR) gene are found in about 4% of AML patients with normal karyotype and are associated with DNMT3a mutations and poor prognosis. Therefore, new anti-leukemia treatments and mouse models are needed for this combinatorial AML genotype. For this purpose, we first generated a Bcor-/- knockout mouse model characterized by impaired erythroid development (macrocytosis and anemia) and enhanced thrombopoiesis, which are both features of myelodysplasia/myeloproliferative neoplasms. We then created and characterized double Bcor-/-/Dnmt3a-/- knockout mice. Interestingly, these animals developed a fully penetrant acute erythroid leukemia (AEL) characterized by leukocytosis secondary to the expansion of blasts expressing c-Kit+ and the erythroid marker Ter119, macrocytic anemia and progressive reduction of the thrombocytosis associated with loss of Bcor alone. Transcriptomic analysis of double knockout bone marrow progenitors revealed that aberrant erythroid skewing was induced by epigenetic changes affecting specific transcriptional factors (GATA1-2) and cell-cycle regulators (Mdm2, Tp53). These findings prompted us to investigate the efficacy of demethylating agents in AEL, with significant impact on progressive leukemic burden and mice overall survival. Information gained from our model expands the knowledge on the biology of AEL and may help designing new rational treatments for patients suffering from this high-risk leukemia.
引用
- Sportoletti P, Sorcini D, Guzman AG, et al. Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice. Leukemia. 2020. PMID: 33159179. doi:10.1038/s41375-020-01075-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。